Transfusion-induced red blood cell alloimmunisation is unhampered in elderly patients
Br J Haematol
.
2022 Oct;199(2):e1-e4.
doi: 10.1111/bjh.18374.
Epub 2022 Jul 29.
Authors
Josine A Oud
1
2
3
,
Dorothea Evers
4
,
Masja de Haas
1
2
5
,
Karen M K de Vooght
6
,
Daan van de Kerkhof
7
,
Nel Som
8
,
Nathalie C V Péquériaux
9
,
Francisca Hudig
10
,
Johanna G van der Bom
1
3
,
Jaap Jan Zwaginga
1
2
Affiliations
1
Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.
2
Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands.
3
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
4
Department of Haematology, Radboud University Medical Center, Nijmegen, The Netherlands.
5
Department of Immunohaematology Diagnostics, Sanquin, Amsterdam, The Netherlands.
6
Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.
7
Department of Clinical Chemistry and Haematology, Catharina Hospital, Eindhoven, The Netherlands.
8
Department of Clinical Chemistry, Amsterdam University Medical Center, VUmc, Amsterdam, The Netherlands.
9
Department of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
10
LabWest, Haga Teaching Hospital, The Hague, The Netherlands.
PMID:
35906191
DOI:
10.1111/bjh.18374
No abstract available
Publication types
Letter
MeSH terms
Aged
Erythrocyte Transfusion* / adverse effects
Erythrocytes
Humans
Isoantibodies*
Substances
Isoantibodies